Geode Capital Management
KPRX icon

Geode Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Geode Capital Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$70.3K Sell
26,717
-21,133
-44% -$53.1K ﹤0.01% 4182
2026
Q1 		$92.3K Buy
47,850
+25,840
+117% +$54.5K ﹤0.01% 4152
2025
Q4 		$43.4K Buy
22,010
+3,157
+17% +$7.2K ﹤0.01% 4261
2025
Q3 		$52.8K Buy
18,853
+280
+2% +$769 ﹤0.01% 4278
2025
Q2 		$53.5K Buy
18,573
+226
+1% +$689 ﹤0.01% 4202
2025
Q1 		$55.2K Buy
18,347
+2,390
+15% +$8.3K ﹤0.01% 4179
2024
Q4 		$53.8K Buy
15,957
+1,474
+10% +$5.09K ﹤0.01% 4232
2024
Q3 		$53K Buy
14,483
+712
+5% +$2.78K ﹤0.01% 4255
2024
Q2 		$57.8K Buy
13,771
+9,636
+233% +$45K ﹤0.01% 4253
2024
Q1 		$26.3K Hold
4,135
– – ﹤0.01% 4443
2023
Q4 		$19.7K Hold
4,135
– – ﹤0.01% 4517
2023
Q3 		$21.9K Buy
+4,135
New +$21.2K ﹤0.01% 4610
2022
Q4 		– Sell
-1,556
Closed -$86K – 4914
2022
Q3 		$86K Buy
1,556
+36
+2% +$2.81K ﹤0.01% 4624
2022
Q2 		$257K Buy
1,520
+48
+3% +$8.03K ﹤0.01% 4121
2022
Q1 		$329K Buy
1,472
+17
+1% +$4.45K ﹤0.01% 4142
2021
Q4 		$791K Buy
1,455
+795
+120% +$448K ﹤0.01% 3823
2021
Q3 		$534K Buy
660
+619
+1,510% +$526K ﹤0.01% 4004
2021
Q2 		$53K Hold
41
– – ﹤0.01% 4649
2021
Q1 		$73K Buy
41
+6
+17% +$13.1K ﹤0.01% 4352
2020
Q4 		$62K Sell
35
-62
-64% -$85.5K ﹤0.01% 4130
2020
Q3 		$137K Hold
97
– – ﹤0.01% 3825
2020
Q2 		$168K Buy
97
+1
+1% +$1.88K ﹤0.01% 3702
2020
Q1 		$179K Buy
96
+2
+2% +$4.3K ﹤0.01% 3580
2019
Q4 		$337K Buy
+94
New +$182K ﹤0.01% 3634

Other funds holding KPRX

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SRL
Scientech Research LLC Jersey City, New Jersey $123M AUM 198.31% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Geode Capital Management's KPRX Position: Q2 2026 in Review

Geode Capital Management reduced its Kiora Pharmaceuticals (KPRX) stake by 44% in Q2 2026, selling an estimated $53.1K and leaving 26,717 shares worth $70.3K. The position accounts for ﹤0.01% of the portfolio, ranked #4182.

Geode Capital Management first reported a position in KPRX in Q4 2019 and has held it in 24 quarters since. The position peaked at $791K in Q4 2021. 22 funds tracked by Wall St. Rank hold KPRX as of Q2 2026.

  • Geode Capital Management held 26,717 shares of Kiora Pharmaceuticals worth $70.3K as of Q2 2026.
  • Geode Capital Management sold 21,133 Kiora Pharmaceuticals shares in Q2 2026, an estimated $53.1K.
  • Kiora Pharmaceuticals made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4182 holding.
  • Geode Capital Management first reported a position in Kiora Pharmaceuticals in Q4 2019 and has held it in 24 quarters since.
  • Geode Capital Management's Kiora Pharmaceuticals position peaked at $791K in Q4 2021.
  • 22 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.